Young Faculty Investigator Award
DEFECTIVE STAT3 SIGNALING IN TREATMENT-REFRACTORY VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH A TRANSCRIPTIONAL SIGNATURE WHICH PREDICTS RESPONSE TO USTEKINUMAB
Lauren Collen, MD, Boston Children's Hospital